ADS-4101
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Pipeline Type
New Formulations and Indications
Phase Of Development
Phase 1
Sponsors and Collaborators
Adamas Pharmaceuticals, Epilepsy Foundation (EF)
Mechanism of Action
Mechanism Description
Voltage Gated Sodium Channels (modified release of lacosamide)
Populations Tested In
Focal Seizures
Other Resources
Special FDA Designation
Nonprofit or Government Support
Nonprofit
Nonprofit or Government Support Description
Epilepsy Foundation - Investment
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
AEDD XV - 2019
Location of Clinical Trials
N/A
Clinical Trial link